Pulmonary hypertension (PH) is a complex, progressive condition characterized by elevated pulmonary artery pressure and pulmonary vascular resistance. It's essential for healthcare professionals to understand the fundamentals of PH to provide optimal care for patients.
PH originates from a variety of causes, leading to different forms of the disease. It often results from remodeling of the pulmonary vasculature due to endothelial dysfunction, vasoconstriction, and vascular remodeling. This process increases the resistance to blood flow through the lungs, causing the right ventricle to work harder, potentially leading to right heart failure.
PH typically presents with nonspecific symptoms such as dyspnea, fatigue, and chest pain. As the disease progresses, symptoms may include syncope and signs of right heart failure. Physical examination may reveal a loud P2 heart sound, jugular venous distention, and lower extremity edema.
Early diagnosis is crucial in managing PH. The diagnostic process involves a combination of clinical assessment, echocardiography, and right heart catheterization. Additional tests may include pulmonary function tests, CT scan, and ventilation/perfusion scan.
Treatment aims to improve symptoms, slow disease progression, and enhance quality of life. Therapeutic options include general measures (oxygen therapy, diuretics), targeted PH therapies (endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, prostacyclins), and in severe cases, lung transplantation.
PH is a complex disease requiring a comprehensive understanding for effective management. Healthcare professionals must be adept in recognizing the signs and symptoms, utilizing appropriate diagnostic tools, and employing effective treatment strategies. Continued research and advancements in treatment offer hope for improved patient outcomes in the future.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation